Brief: Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Finland

Herantis Pharma Oyj

12/06/2017 07:00

June 12 (Reuters) - HERANTIS PHARMA OYJ  HRTIS.HE : 
    * HERANTIS PHARMA'S CLINICAL STUDY WITH CDNF IN PARKINSON'S 
DISEASE AUTHORIZED IN FINLAND, COMPANY EXPANDS ON DEVELOPMENT 
PLAN 
 
Source text for Eikon:  ID:nGNE16dqJV  
Further company coverage:  HRTIS.HE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))